Randomized clinical trials remain the gold standard for establishing a medication's effects, producing the evidence by which ...
MS is currently treated with 'disease-modifying' medicines (e.g. interferon beta, glatiramer acetate, natalizumab, fingolimod, alemtuzumab, teriflunomide, and dimethyl fumarate). These medicines can ...
The most-read journal articles of 2025 include those on emotional eating, procrastination and links between screentime and depression.